Research Areas

A 52-Week, Randomized, Double Blind, Double Dummy, Active and Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of An Investigational Medication Compared to Glimepiride or Placebo Added to Metformin in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin Monotherapy

A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of An Investigational Insulin in Study Participants with Type 2 Diabetes Mellitus Previously Treated with Basal Insulin

An Investigational Trial Comparing the Efficacy and Safety of Once Weekly Investigational Insulin Versus Once Daily Insulin Glargine, Both in Combination With Metformin, With or Without DPP-4 Inhibitors, In Insulin Naive Subjects With Type 2 Diabetes Mellitus

A Phase 1b, Double-Blind, Placebo-Controlled, Randomized, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, PK and PD of an Investigational Medication in Healthy Male Subjects and Subjects with T2DM

A 16 week Phase 2b Randomized, Double Blind Placebo Controlled Parallel Group Study to Evaluate the Efficacy and Safety of Twice Daily Investigational Medication Administration in Adults with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin or Diet and Exercise

A Phase 2, Parallel, Comparator‐Controlled Trial to Evaluate the Safety and Efficacy of An Investigational Medication in Insulin‐Naïve Patients with Type 2 Diabetes Mellitus

A Study of An Investigational Medication in Patients with Type 2 Diabetes Using Continuous Glucose Monitoring

An Investigational Medication Compared to A Marketed Glucagon For Induced Hypoglycemia Rescue in Adults with Type 1 Diabetes: A Phase 3B Multi-centered, Randomized, Controlled, Single Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety

An Investigational Glucagon Delivery Device compared to An Approved Glucagon Delivery Kit for Induced Hypoglycemia Rescue in Adult Patients With Type 1 Diabetes: A Phase 3, Multi-Center, Randomized, Controlled, Single-Blind, 2-Way Crossover Study to Evaluate Efficacy and Safety

A Randomized, Double-Blind, Parallel-Group Trial to Confirm the Clinical Efficacy and Safety of An Investigation Medication in the Rescue Treatment of Hypoglycemia in Subjects with Type 1 Diabetes Mellitus (T1DM) Compared to Placebo

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Doses of An Investigational Drug in Subjects with Type 1 Diabetes Mellitus

A Prospective, Randomized, Double-Blind Comparison of An Investigational Drug to Humalogin Adults with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion PRONTO-Pump-2

Collection of PBMC from Individuals with Type 1 Diabetes for Use in Assays

A Phase 2, Randomized, Parallel, Open‐Label Comparator‐Controlled Trial to Evaluate the Safety and Efficacy of An Investigational Medication in Study Participants with Type 1 Diabetes Mellitus Previously Treated with Multiple Daily Injection Therapy

Development of Autoreactive T Cell Lines From Individuals with Type 1 Diabetes

A Randomized, Double-Blind, Placebo-Controlled and Open-Label, Active-Controlled, Parallel-Group, Multicenter, Dose-Ranging Study to Evaluate the Safety and Efficacy of An Investigational Medication in Non-Diabetic Severely Obese Subjects.

Effect and Safety of An Approved Injectable Medication Once-Weekly in Subjects Who Are Overweight or Obese.

A Multi-Center, Double-Blind, Sham-Controlled, Randomized Trial of An Investigational Device in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy.

A Multicenter, Randomized, Double Blind, Dose Conversion Study to Evaluate the Safety and Efficacy of Hormone Replacement Therapy with two marketed Thyroid treatments in Previously Hypothyroid Participants Who are Euthyroid on T4 Replacement Therapy

Ambulatory Blood Pressure Monitoring in An Investigational Oral Testosterone in Hypogonadal Men